Antimicrobial drug discovery


Session 2 & 4: Antimicrobial drug discovery

Monday 3  April & Tuesday 4 April
Chairs: Dr Mark Blaskovich and Professor Matthew Cooper

New antibiotics are desperately needed to treat drug-resistant bacterial infections – with novel chemotypes acting on novel targets a rare commodity. 
This session will examine early discovery research that could lead to the first next new class of antibiotics in decades.

Supported By